Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment Refractory MAC Lung Disease”

3 trials

Showing 3 of 3 results

Large-scale testing (Phase 3)Ended earlyNCT06418711
What this trial is testing

ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension

Who this might be right for
MAC Lung DiseaseTreatment Refractory MAC Lung DiseaseMycobacterium Infections, Nontuberculous
Mannkind Corporation 132
Large-scale testing (Phase 3)Ended earlyNCT05327803
What this trial is testing

Study of Epetraborole in Patients With Treatment-refractory MAC Lung Disease

Who this might be right for
MAC Lung DiseaseTreatment Refractory MAC Lung Disease
AN2 Therapeutics, Inc 177
Large-scale testing (Phase 3)Study completedNCT04630145
What this trial is testing

Bedaquiline Administered as Part of a Treatment Regimen With Clarithromycin and Ethambutol in Adult Patients With Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD)

Who this might be right for
Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD)
Janssen Pharmaceutical K.K. 129

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation